Rosenbaum Jay D. Edwards Lifesciences Corp Transaction History

Rosenbaum Jay D.

$3.04 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $18,936 - $21,550	-255 Reduced 8.74%	2,664 $220,000
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $53,820 - $68,902	-788 Reduced 21.26%	2,919 $217,000
Q3 2022 Nov 09, 2022	SELL	$82.37 - $107.29 $29,653 - $38,624	-360 Reduced 8.85%	3,707 $306,000
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $1,730 - $2,565	-20 Reduced 0.49%	4,067 $387,000
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $26,611 - $33,496	261 Added 6.82%	4,087 $481,000
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $278,795 - $342,512	-2,621 Reduced 40.65%	3,826 $496,000
Q3 2021 Oct 26, 2021	SELL	$102.91 - $122.75 $35,709 - $42,594	-347 Reduced 5.11%	6,447 $730,000
Q2 2021 Jul 14, 2021	SELL	$83.84 - $104.76 $146,300 - $182,806	-1,745 Reduced 20.44%	6,794 $703,000
Q1 2021 Apr 26, 2021	SELL	$78.68 - $90.67 $6,530 - $7,525	-83 Reduced 0.96%	8,539 $714,000
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $73,410 - $93,419	-1,024 Reduced 10.62%	8,622 $787,000
Q3 2020 Nov 03, 2020	SELL	$67.19 - $87.44 $116,104 - $151,096	-1,728 Reduced 15.19%	9,646 $770,000
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $424,415 - $567,583	7,376 Added 184.49%	11,374 $786,000
Q1 2020 Apr 22, 2020	SELL	$52.41 - $81.0 $136,213 - $210,519	-2,599 Reduced 39.4%	3,998 $754,000
Q4 2019 Jan 27, 2020	SELL	$71.7 - $82.09 $6,524 - $7,470	-91 Reduced 1.36%	6,597 $1.54 Million
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $152,151 - $186,462	-2,472 Reduced 26.99%	6,688 $1.47 Million
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $34,948 - $40,385	-627 Reduced 6.41%	9,160 $1.69 Million
Q1 2019 Apr 17, 2019	SELL	$47.89 - $64.05 $65,705 - $87,876	-1,372 Reduced 12.3%	9,787 $1.87 Million
Q4 2018 Jan 14, 2019	SELL	$46.41 - $56.94 $42,465 - $52,100	-915 Reduced 7.58%	11,159 $1.71 Million
Q3 2018 Oct 23, 2018	SELL	$45.7 - $58.03 $12,110 - $15,377	-265 Reduced 2.15%	12,074 $2.1 Million
Q2 2018 Jul 26, 2018	SELL	$42.45 - $51.3 $30,776 - $37,192	-725 Reduced 5.55%	12,339 $1.8 Million
Q1 2018 Apr 19, 2018	SELL	$37.19 - $47.45 $61,400 - $78,339	-1,651 Reduced 11.22%	13,064 $1.82 Million
Q4 2017 Feb 08, 2018	SELL	$33.79 - $39.39 $17,570 - $20,482	-520 Reduced 3.41%	14,715 $1.66 Million
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $552,878 - $591,575	15,235	15,235 $1.67 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

News

Stay updated on Rosenbaum Jay D. with notifications on news.

Account